John R Koethe

18PUBLICATIONS
87CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Behavioural epidemiologyGenome structure and regulationGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 30, 2026
Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons with HIV Starting Antiretroviral Therapy in the United States and Canada.

|Mar 18, 2026
A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).

John R Koethe, Jordan E Lake, Amy Kantor

|Jan 02, 2026
Metabolic and inflammatory axes of insulin resistance in normoglycemic adults with high HIV burden.

Situmbeko Liweleya, Brian Halubanza, Lweendo Muchaili

|Dec 01, 2025
Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.

Todd Hulgan, Kristine M Erlandson, Yuki Bradford

|Nov 24, 2025
Risk of Coronary Artery Disease Associated With Transitions in Metabolic Health in a Clinical Cohort of 69 272.

Megan M Shuey, Rebecca T Levinson, Megan E Vogel

|Nov 24, 2025
Factors Associated With Weight Change After Continuing or Switching to a Doravirine-based Regimen.

Chloe Orkin, John R Koethe, Princy N Kumar

Pageof 3

Frequent Collaborators

3 joint publications

Sepiso K Masenga

3 joint publications

Jordan E Lake

3 joint publications

Wilbroad Mutale

3 joint publications

Douglas C Heimburger